January 3, 2013 | For Immediate Release

Introduces Key New Executives

Milford, MA (January 3, 2013) – SeraCare Life Sciences, a portfolio company of Linden Capital Partners serving the in vitro diagnostics and clinical laboratory markets, has reorganized into three market-based commercial business units: IVD Research, IVD Processing and Clinical Laboratory. The new structure is designed to deliver greater insight into customer needs while streamlining business processes. In addition, SeraCare now has a complete senior management team, welcoming five new key executives to lead the Company’s commercial business units as well as operations, research and development, and quality organizations.

“Our industry is entering a period of great change as new diagnostics technologies enable an unprecedented level of personalized medicine,” said Charles Mamrak, CEO of SeraCare. “Our customers need our help in turning these changes into business opportunities. Allowing our customer-facing personnel to focus on a single, key market will make it easier for them to anticipate and meet these customers’ needs.”

To lead SeraCare to the next phase of its growth and focus on precision medicine, SeraCare welcomes five key executives:

Russell Garlick, Ph.D. serves as Chief Scientific Officer, focusing on expansion of the Company’s R&D organization and product development pipeline. Dr. Garlick has worked on the development, regulatory approval and launch of a variety of technologies and assays, including an HIV AIDS patient management program, molecular genomics technologies and HIV drug discovery systems. Prior to joining SeraCare, he was co-founder of Life Sciences Group and also served as CEO and CTO of Protein Forest, Inc. Dr. Garlick also held executive R&D positions at PerkinElmer Life Sciences and DuPont NEN Life Sciences. Dr. Garlick has both a Ph.D. and M.S. in Biomedical Sciences, Medicinal Chemistry from the Barnett Institute at Northeastern University as well as a B.S. in Biology from University of Massachusetts at Lowell.

Cheri Walker, Ph.D. has joined as Chief Commercial Officer and will act as the head of the IVD Research and Clinical Laboratory business units in addition to overseeing corporate development activities. Prior to this position, Dr. Walker consulted with private equity firms and both diagnostic and life science tools companies on marketing, strategy and corporate development activities. In the past, she has held senior level corporate development, marketing and business unit leadership roles at Charles River Laboratories, QIAGEN and Invitrogen (now Life Technologies) and was the stock analyst covering the Life Science Tools companies for Deutsche Bank. Dr. Walker holds a Ph.D. in Human and Molecular Genetics from Baylor College of Medicine and a B.A. in Biology from Swarthmore College.

Ann McCormick is SeraCare’s new Chief Operating Officer. She brings extensive life science industry experience in manufacturing, laboratory and executive roles. Most recently, she co-founded and managed SeraMetrix Corporation where she was involved with developing and manufacturing protein biomarkers for oncology and autoimmune applications. Prior to that role, Ms. McCormick worked with Invitrogen (now Life Technologies) for over 12 years where she held numerous manufacturing and operational leadership positions. As Vice President of Manufacturing Operations, she managed the Company’s global production sites including GMP compliant facilities. Before Life Technologies, Ms. McCormick was a Senior Scientist with Beckman where she helped developed recombinant proteins for HIV assays. She holds an M.S. in Microbiology from Indiana State University and a B.S. in Biology from Christopher Newport College.

Joe Kozma joins SeraCare as Vice President of IVD Process Solutions. Previously, Mr. Kozma held executive positions at Serologicals and Millipore. He was also co-founder of Intergen, a manufacturer of biological and recombinant reagents for research and manufacturing of biopharmaceutical and diagnostic products. Mr. Kozma brings rich experience working with IVD manufacturers and will build and manage the IVD Process Solutions group to better meet the needs of these organizations. Mr. Kozma holds a Bachelor of Science degree from Ball State University.

Lisa Alexander serves as SeraCare’s Vice President, Quality and Regulatory where she will be focused on driving SeraCare’s mission to meet or surpass our customers’ quality expectations, regulatory requirements and industry standards. She brings significant experience leading quality and regulatory teams in the life sciences and diagnostic industries including her most recent role as VP, Quality and Regulatory Affairs at Xcellerex (GE Healthcare). Prior to Xcellerex, she was Director, Corporate QA/RA at Millipore Corporation and held leadership roles in Quality at Amgen, GTC Biotherapeutics and BioReliance. Ms. Alexander holds an M.S. in Environmental and Occupational Health and Safety from Anna Maria College, an M.B.A. from Northeastern University and a B.S. in Bio-Psychology from Tufts University.